Lilly's announcement that it would make its experimental weight-loss pill in the U.S. comes amid administration pressure on ...

By making the expected blockbuster pill in the U.S., Lilly may be able to avoid the impact of Trump’s sweeping tariffs, ...

Eli Lilly said in February that it will invest at least $27 billion to build four new manufacturing sites in the U.S. as ...

Pharmaceutical giant Eli Lilly (LLY) has promised to make its new weight-loss pill in the U.S. as President Donald Trump ...

Eli Lilly plans to make its experimental drug orforglipron in the U.S. after it secures regulatory approval, says CEO Dave ...

Janet Yellen remains wrong on a host of issues — including inflation, sanctions enforcement and U.S. interest rates.

Eli Lilly surged during Thursday's trading session after promising test results came out of the pharmaceutical company's ...

In an hour-long meeting at Eli Lilly and Company’s headquarters in Indianapolis on April 15, the pharmaceutical company’s top ...

Eli Lilly's oral GLP-1 drug orforglipron showed strong Phase 3 results with 7.9% weight loss and good tolerability, ...

Johnson & Johnson’s Joaquin Duato is no longer the highest paid CEO in pharma. Meanwhile, just two women make the top 10.

Levies on Americans’ daily prescriptions and other medicines could raise costs, spur rationing and lead to shortages of ...